title: Pancreatic Islet Responses to Metabolic Trauma.
abstract: Carbohydrate, lipid, and protein metabolism are largely controlled by the interplay of various hormones, which includes those secreted by the pancreatic islets of Langerhans. While typically representing only 1% to 2% of the total pancreatic mass, the islets have a remarkable ability to adapt to disparate situations demanding a change in hormone release, such as peripheral insulin resistance. There are many different routes to the onset of insulin resistance, including obesity, lipodystrophy, glucocorticoid excess, and the chronic usage of atypical antipsychotic drugs. All of these situations are coupled to an increase in pancreatic islet size, often with a corresponding increase in insulin production. These adaptive responses within the islets are ultimately intended to maintain glycemic control and to promote macronutrient homeostasis during times of stress. Herein, we review the consequences of specific metabolic trauma that lead to insulin resistance and the corresponding adaptive alterations within the pancreatic islets.
authors.affiliation: *Laboratory of Islet Biology and Inflammation, Pennington Biomedical Research Center, Baton Rouge, Louisiana †Department of Surgery, Graduate School of Medicine, University of Tennessee Health Science Center, Knoxville, Tennessee.
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Burke
authors.forename: Michael D
authors.initials: MD
authors.lastname: Karlstad
authors.forename: J Jason
authors.initials: JJ
authors.lastname: Collier
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects; D005938:Glucocorticoids / Q000378:metabolism; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics / Q000502:physiology; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D008060:Lipodystrophy / Q000378:metabolism; D009765:Obesity / Q000378:metabolism
chemical_list: D014150:Antipsychotic Agents; D005938:Glucocorticoids